Cargando…

Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing

Optimization of antibiotic dosing is a treatment intervention that is likely to improve outcomes in severe infections. The aim of this retrospective study was to describe the therapeutic exposure of steady state piperacillin concentrations (c(PIP)) and clinical outcome in critically ill patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiriac, Ute, Richter, Daniel C., Frey, Otto R., Röhr, Anka C., Helbig, Sophia, Preisenberger, Judit, Hagel, Stefan, Roberts, Jason A., Weigand, Markus A., Brinkmann, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227218/ https://www.ncbi.nlm.nih.gov/pubmed/34205135 http://dx.doi.org/10.3390/antibiotics10060667

Ejemplares similares

Software- and TDM-Guided Dosing of Meropenem Promises High Rates of Target Attainment in Critically Ill Patients
por: Chiriac, Ute, et al.
Publicado: (2023)

Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
por: Felton, T. W., et al.
Publicado: (2014)

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
por: Greppmair, Sebastian, et al.
Publicado: (2023)

Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment
por: Chiriac, Ute, et al.
Publicado: (2021)

Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial
por: Hagel, Stefan, et al.
Publicado: (2019)

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?
por: Udy, Andrew A, et al.
Publicado: (2015)

We need to optimize piperacillin-tazobactam dosing in critically ill patients—but how?
por: Cotta, Menino Osbert, et al.
Publicado: (2016)

Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: Schatz, Lea Marie, et al.
Publicado: (2023)

Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
por: Hagel, Stefan, et al.
Publicado: (2022)

Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
por: Hagel, Stefan, et al.
Publicado: (2022)

Excessive unbound cefazolin concentrations in critically ill patients receiving veno-arterial extracorporeal membrane oxygenation (vaECMO): an observational study
por: Booke, Hendrik, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of High-Dose Piperacillin–Tazobactam in Obese Patients
por: Veillette, John J., et al.
Publicado: (2021)

Piperacillin–tazobactam induced bicytopenia in low cumulative treatment doses
por: Chen, Chien-Chou, et al.
Publicado: (2019)

Validation and Application of an HPLC-UV Method for Routine Therapeutic Drug Monitoring of Dalbavancin
por: Chiriac, Ute, et al.
Publicado: (2022)

Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
por: Besnard, Thibaud, et al.
Publicado: (2019)

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
por: Felton, T. W., et al.
Publicado: (2013)

220. Effectiveness of Piperacillin/tazobactam Loading Dose for Extended Infusion Dosing Among Patients with Gram-negative Bacteremia (EZ-LD)
por: Patel, Savan, et al.
Publicado: (2023)

Individualised dosing of antibiotics in ICU patients: timing, target and model selection matter
por: Liebchen, Uwe, et al.
Publicado: (2023)

Pharmacodynamic Target Attainment for Meropenem and Piperacillin/Tazobactam Using a PK/PD-based Dosing Calculator in Critically Ill Patients
por: Heil, Emily, et al.
Publicado: (2017)

Linguistic and cultural adaptation to the Portuguese language of antimicrobial dose adjustment software
por: da Silva, Samuel Dutra, et al.
Publicado: (2020)

Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy
por: Hahn, Jongsung, et al.
Publicado: (2021)

Software for dose adjustment of antimicrobials. Implications for plasma concentrations and pratical limitations
por: Alves, Geisa Cristina da Silva, et al.
Publicado: (2020)

Penetration of Piperacillin/Tazobactam Into Gynecologic Tissues Following a Single Loading Dose Prior to Hysterectomy
por: O'Brien, William F., et al.
Publicado: (1994)

Clinical Outcomes with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Systematic Review and Meta-Analysis
por: Yang, Hui, et al.
Publicado: (2015)

An automated dose verification software for brachytherapy
por: Wang, Xianliang, et al.
Publicado: (2018)

Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software
por: Roberts, Jason A., et al.
Publicado: (2022)

A New Framework to Implement Model-Informed Dosing in Clinical Guidelines: Piperacillin and Amikacin as Proof of Concept
por: Hartman, Stan J. F., et al.
Publicado: (2020)

Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
por: König, Christina, et al.
Publicado: (2021)

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
por: Póvoa, Pedro, et al.
Publicado: (2021)

Correction: König et al. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649
por: König, Christina, et al.
Publicado: (2021)

Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen
por: Thorsted, Anders, et al.
Publicado: (2019)

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia
por: Ishihara, Noriyuki, et al.
Publicado: (2020)

Isobio software: biological dose distribution and biological dose volume histogram from physical dose conversion using linear-quadratic-linear model
por: Jaikuna, Tanwiwat, et al.
Publicado: (2017)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
por: Lyster, Haifa, et al.
Publicado: (2023)

Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
por: Roberts, Jason A, et al.
Publicado: (2014)

1409. Evaluation of Alternative Piperacillin–tazobactam Dosing Strategies Against ESBL-Producing Enterobacteriaceae Using a Hollowfiber Infection Model
por: Abodakpi, Henrietta, et al.
Publicado: (2018)

Implementation of an Extended-Infusion Piperacillin-Tazobactam Dosing Protocol: Unexpected Findings when Monitoring Safety and Compliance with Smart Pump Technology
por: J. Rhodes, Nathaniel, et al.
Publicado: (2019)

BMDExpress: a software tool for the benchmark dose analyses of genomic data
por: Yang, Longlong, et al.
Publicado: (2007)

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients
por: Jonmarker, Sandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6rq7nbs753ckl2g3hl9in0uchu